Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Renewed understanding of “junk” DNA drives new biotech models
Researchers find that "junk" DNA is anything but, marking a potential turning point in biotech research and product development.
2. NxStage keeps fighting Medicare rules for home hemodialysis
Dialysis devices maker NxStage Medical calls on the Centers for Medicare & Medicaid Services to update its "insufficient and inequitable" payment rules for home hemodialysis.
1. More legal troubles for Medtronic?
Medtronic reveals a year-old Dept. of Justice probe into the medical device company’s insulin pump replacement practices.
